Geelong’s rates of gonorrhoea and infectious syphilis have risen, as experts warn of a hidden epidemic of sexually ...

Cardinal Mafi of Tonga and Cardinal Ribat of Papua New Guinea will travel to Rome to take part. The Vatican confirmed ...

Acupressure is a natural remedy that can relieve pain, nausea, and other migraine symptoms. Discover 14 points for relief ...

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the ...

Hispanic/Latinx and White children have more than twofold and threefold increased odds of linkage to care, respectively, than Black children.

From October this year, all newborns will be vaccinated against Hepatitis B Virus (HBV) at birth, the Programme Manager of the Expanded Programme on Immunisation (EPI), Dr Kwame Amponsah-Achiano ...

PBGENE-HBV is designed to potentially cure chronic hepatitis B by eliminating the root cause of the virus. The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an ...

The closure of the Centers for Disease Control and Prevention (CDC)’s Division of Viral Hepatitis in the wake of the administration’s restructuring of the Department of Health and Human Services ...

CONCORD, Mass.--(BUSINESS WIRE)--ClearB Therapeutics, Inc., a company developing therapeutic vaccines designed to drive a functional cure for Hepatitis B, announced today that an abstract will be ...

Hepatitis A and B are the most common vaccine-preventable diseases for travelers; nevertheless, up to 50% of confirmed cases of hepatitis A and B in Europe are still acquired during travel.

Arbutus Biopharma Corporation (Nasdaq: ABUS) announced the acceptance of five abstracts, including a late-breaking study, for ...